IMMUPHARMA

immupharma-logo

ImmuPharma focuses in developing pioneering and novel drugs in specialist therapeutic areas where there is a distinct lack of existing treatments, avoiding primary care (diseases treated by GPs) where many treatments exist. This is consistent with the trends in the pharmaceutical industry. Since our foundation, our research strategy has been to work closely with the largest fundamental research organisation in Europe, the Centre National de la Recherche Scientifique, (CNRS) in France. This collaboration enables us to access innovative research with substantial embedded value at a relatively low cost, and to work with many leading scientists and doctors. ImmuPharma has exclusive rights to all its intellectual property assets.

#SimilarOrganizations #People #Financial #Website #More

IMMUPHARMA

Industry:
Biotechnology Developer Tools Life Science Pharmaceutical

Founded:
1999-01-01

Address:
Westminster, Westminster, United Kingdom

Country:
United Kingdom

Website Url:
http://www.immupharma.co.uk

Total Employee:
1+

Status:
Active

Contact:
(442) 071-5240

Email Addresses:
[email protected]

Total Funding:
12.57 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins Mobile Non Scaleable Content Sitelinks Search Box


Similar Organizations

axcella-logo

Axcella

Axcella is a biotechnology company providing therapeutics development solutions.

omass-technologies-logo

OMass Technologies

OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

versameb-logo

Versameb

Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.

Current Employees Featured

not_available_image

Robert Zimmer
Robert Zimmer President & Chief Science Officer @ ImmuPharma
President & Chief Science Officer
1970-05-01

stephane-mery_image

Stephane Mery
Stephane Mery Non-Executive Director @ ImmuPharma
Non-Executive Director
2015-05-01

dimitri-f-dimitriou_image

Dimitri F Dimitriou
Dimitri F Dimitriou CEO @ ImmuPharma
CEO

jean-paul-briand_image

Jean-Paul Briand
Jean-Paul Briand Research Director at CNRS & Co-founder @ ImmuPharma
Research Director at CNRS & Co-founder

Founder


dimitri-f-dimitriou_image

Dimitri F Dimitriou

gilles-guichard_image

Gilles Guichard

jean-paul-briand_image

Jean-Paul Briand

Stock Details


Company's stock symbol is LSE:IMM

Investors List

lanstead-capital_image

Lanstead Capital

Lanstead Capital investment in Post-IPO Equity - ImmuPharma

Official Site Inspections

http://www.immupharma.co.uk Semrush global rank: 2.19 M Semrush visits lastest month: 8.96 K

  • Host name: 217-160-0-252.elastic-ssl.ui-r.com
  • IP address: 217.160.0.252
  • Location: Germany
  • Latitude: 51.2993
  • Longitude: 9.491
  • Timezone: Europe/Berlin

Loading ...

More informations about "ImmuPharma" on Search Engine